YPrime
YPrime offers technology solutions and consulting services to enhance the efficiency and quality of clinical trials globally, supporting over 100,000 patients in 83 countries.
Services
YPrime provides a range of technology solutions designed to streamline clinical trials. Their core services include a technology platform featuring eCOA, IRT, eConsent, and patient engagement modules. Additionally, they offer consulting services aimed at optimizing clinical trial processes and data collection. YPrime’s services are geared towards enhancing clinical trial participation and compliance through a patient-centered approach.
Technology Platform
YPrime's technology platform is pre-validated and configurable to improve data quality and trial efficiency. This platform includes modules like electronic Clinical Outcome Assessment (eCOA), Interactive Response Technology (IRT), and electronic Consent (eConsent). The technology aims to reduce clinical trial timelines by enabling faster startup times for eCOA and IRT. Their platform supports over 100,000 patients across 83 countries, facilitating the execution of over 650 studies globally.
Patient Engagement
A key feature of YPrime's offering is its emphasis on patient-centered approaches to enhance clinical trial participation and compliance. Their technology solutions include patient engagement modules designed to support and improve participant involvement in clinical trials. This approach helps to ensure higher compliance rates and better overall trial outcomes.
Clinical Research Organization (CRO) Support
YPrime offers comprehensive support to Clinical Research Organizations (CROs) to help partners achieve their study goals. Their technology platforms and consulting services provide critical resources to optimize clinical trial processes. By facilitating efficient data collection and management, YPrime aids CROs in meeting their objectives and improving trial outcomes.
Global Reach and Experience
YPrime operates in 19 therapeutic areas and supports clinical trials in over 83 countries. They have engaged over 100,000 patients and implemented more than 650 studies globally. This extensive experience and wide-reaching support underscore their capability to manage and streamline international clinical trials across diverse therapeutic fields.